Syntekabio

Syntekabio, Inc. is a precision medicine new drug development company that utilizes AI technology driven by genomic big data. Syntekabio, Inc., established in 2009, is a bio-innovative enterprise that acquired the "supercomputing technology dedicated to genetic testing" from the Electronics and Telecommunications Research Institute (ETRI) of South Korea in 2014.It possesses the algorithm-based personal genome mapping platform technology (PMAP) and operates as an in silico genomic big data laboratory company, managing and analyzing genomes and large-scale data using high-performance and highly efficient supercomputers.